Younossi ZM - Search Results

1

Increased cancer rates in patients with chronic hepatitis C.

Nyberg AH, Sadikova E, Cheetham C, Chiang KM, Shi JX, Caparosa S, Younossi ZM, Nyberg LM. Nyberg AH, et al. Among authors: younossi zm. Liver Int. 2020 Mar;40(3):685-693. doi: 10.1111/liv.14305. Epub 2019 Dec 22. Liver Int. 2020. PMID: 31755208

2

Treatment options for nonresponders and relapsers to initial therapy for hepatitis C.

Duncan M, Younossi Z. Duncan M, et al. Cleve Clin J Med. 2003 Sep;70 Suppl 4:S21-6. doi: 10.3949/ccjm.70.suppl_4.s21. Cleve Clin J Med. 2003. PMID: 14558642 Free article. Review.

3

Risk factors for hepatocellular carcinoma in patients with cirrhosis.

Sarbah SA, Gramlich T, Younoszai A, Osmack P, Goormastic M, Grosso L, Cooper JN, Di Bisceglie A, Seneca R, Younossi ZM. Sarbah SA, et al. Among authors: younossi zm. Dig Dis Sci. 2004 May;49(5):850-3. doi: 10.1023/b:ddas.0000030098.75759.32. Dig Dis Sci. 2004. PMID: 15259508

4

Obesity and non-alcoholic fatty liver disease in chronic hepatitis C.

Younossi ZM, McCullough AJ, Ong JP, Barnes DS, Post A, Tavill A, Bringman D, Martin LM, Assmann J, Gramlich T, Mullen KD, O'Shea R, Carey WD, Ferguson R. Younossi ZM, et al. J Clin Gastroenterol. 2004 Sep;38(8):705-9. doi: 10.1097/01.mcg.0000135372.10846.2a. J Clin Gastroenterol. 2004. PMID: 15319656

5

Impact of adherence on the outcome of antiviral therapy for chronic hepatitis C.

Mulhall BP, Younossi Z. Mulhall BP, et al. J Clin Gastroenterol. 2005 Jan;39(1 Suppl):S23-7. doi: 10.1097/01.mcg.0000145538.43865.72. J Clin Gastroenterol. 2005. PMID: 15597024

6

Hepatic gene expression in patients with obesity-related non-alcoholic steatohepatitis.

Younossi ZM, Gorreta F, Ong JP, Schlauch K, Del Giacco L, Elariny H, Van Meter A, Younoszai A, Goodman Z, Baranova A, Christensen A, Grant G, Chandhoke V. Younossi ZM, et al. Liver Int. 2005 Aug;25(4):760-71. doi: 10.1111/j.1478-3231.2005.01117.x. Liver Int. 2005. PMID: 15998427

7

Approach to the diagnosis and treatment of nonalcoholic fatty liver disease.

Ong JP, Younossi ZM. Ong JP, et al. Among authors: younossi zm. Clin Liver Dis. 2005 Nov;9(4):617-34, vi. doi: 10.1016/j.cld.2005.07.002. Clin Liver Dis. 2005. PMID: 16207567 Review.

8

Microarray technology in the study of obesity and non-alcoholic fatty liver disease.

Baranova A, Schlauch K, Gowder S, Collantes R, Chandhoke V, Younossi ZM. Baranova A, et al. Among authors: younossi zm. Liver Int. 2005 Dec;25(6):1091-6. doi: 10.1111/j.1478-3231.2005.01183.x. Liver Int. 2005. PMID: 16343057 Review.

9

Depression, anemia and health-related quality of life in chronic hepatitis C.

Dan AA, Martin LM, Crone C, Ong JP, Farmer DW, Wise T, Robbins SC, Younossi ZM. Dan AA, et al. Among authors: younossi zm. J Hepatol. 2006 Mar;44(3):491-8. doi: 10.1016/j.jhep.2005.11.046. Epub 2005 Dec 27. J Hepatol. 2006. PMID: 16427157

10

Fatigue and health-related quality of life (HRQL) in chronic hepatitis C virus infection.

Kallman J, O'Neil MM, Larive B, Boparai N, Calabrese L, Younossi ZM. Kallman J, et al. Among authors: younossi zm. Dig Dis Sci. 2007 Oct;52(10):2531-9. doi: 10.1007/s10620-006-9708-x. Epub 2007 Apr 4. Dig Dis Sci. 2007. PMID: 17406828

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

629 results

Search Page